New birth control shot could last months
NCT ID NCT07222228
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new contraceptive injection called levonorgestrel butanoate, given under the skin. It aims to prevent pregnancy with just two shots, spaced about 4 months apart. The trial involves 165 healthy women aged 18-35 and will track effectiveness and safety over 8 menstrual cycles.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Levonorgestrel butanoate injection
- What this could lead to
- If successful, this could provide a new, longer-lasting birth control option for women, requiring only two injections over 8 months.
- What could go wrong
- This is an early phase 2b trial with only 165 participants, so results may not apply to everyone. Side effects or lower-than-expected effectiveness could limit its use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FEMALE CONTRACEPTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Pilates showdown: which type boosts balance best after one session?
- MOTIVATIONAL TALKING TRIAL AIMS TO STOP BABY BOTTLE TOOTH DECAY
- Electric shocks to legs may boost pelvic floor strength, study finds
- Protein powder promises better blood sugar for women – but is it hype?
- Magnesium may boost sleep and brain power, small trial hints
- Can a workout fight breast cancer cells? new study investigates